Weed (BUDZ) Notes Payables (2010 - 2025)
Weed (BUDZ) posted quarterly Notes Payables of $348018.0 for Q3 2025, up 9406.09% year-over-year from $3661.0 in Q3 2024, and up 0.74% quarter-over-quarter from $345455.0 in Q2 2025.
Weed (BUDZ) Notes Payables (2010 - 2025) Analysis & Trends
Weed's Notes Payables history runs 12 years deep, the most recent figure standing at $348018.0 for Q3 2025.
- In Q3 2025, Notes Payables rose 9406.09% year-over-year to $348018.0; the TTM figure through Sep 2025 stood at $348018.0 (up 9406.09% YoY), while the FY2024 annual figure was $423328.0, up 11463.18% from the prior year.
- Notes Payables for Q3 2025 stood at $348018.0, up from $345455.0 in the prior quarter.
- The five-year high for Notes Payables was $897661.0 in Q2 2022, with the low at $3661.0 in Q4 2022.
- The 5-year median for Notes Payables is $75822.0 (2021), against an average of $246495.9.
- The sharpest annual moves came in 2023 and 2024: Notes Payables sank 99.59% in 2023, then surged 11463.18% in 2024.
- Weed's Notes Payables stood at $65607.0 in 2021, then sank by 94.42% to $3661.0 in 2022, then changed by 0.0% to $3661.0 in 2023, then soared by 11463.18% to $423328.0 in 2024, then retreated by 17.79% to $348018.0 in 2025.
- Business Quant data shows BUDZ's Notes Payables at $348018.0 in Q3 2025, $345455.0 in Q2 2025, and $340891.0 in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Weed | 3.13 Mn | 3.13 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 348,018.00 |
| Jun 30, 2025 | 345,455.00 |
| Mar 31, 2025 | 340,891.00 |
| Dec 31, 2024 | 423,328.00 |
| Sep 30, 2024 | 3,661.00 |
| Jun 30, 2024 | 3,661.00 |
| Mar 31, 2024 | 3,661.00 |
| Dec 31, 2023 | 3,661.00 |
| Sep 30, 2023 | 3,661.00 |
| Jun 30, 2023 | 3,661.00 |
| Mar 31, 2023 | 3,661.00 |
| Dec 31, 2022 | 3,661.00 |
| Sep 30, 2022 | 763,454.00 |
| Jun 30, 2022 | 897,661.00 |
| Mar 31, 2022 | 802,999.00 |
| Dec 31, 2021 | 65,607.00 |
| Sep 30, 2021 | 303,700.00 |
| Jun 30, 2021 | 75,822.00 |
| Mar 31, 2021 | 287,200.00 |
| Dec 31, 2020 | 258,200.00 |